Clinical Trials Browser

Phase 1 × Breast Neoplasms × Histamine Antagonists × Clear all

NCT04568902 2025-10-23

Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Phase 1 Completed

Breast Neoplasms